Chlorhexidine Gluconate for Prevention of Ventilator Associated Pneumonia in Children.

• Status: Unknown status
• Trial end date: 2016-12-01
• Target enrollment: 0
• Participant gender: All

Summary

To determine the efficacy of prophylaxis with 0.12% chlorhexidine gluconate compared with placebo to prevent ventilator associated pneumonia in children admitted to a pediatric critical care unit.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Sinaloa Pediatric Hospital
• Treatments: Chlorhexidine; Chlorhexidine gluconate; Pharmaceutical Solutions

Criteria

Inclusion Criteria:

• Children aged 1 month to 18 years admitted to the intensive care unit.

• Intubated for more than 48 hours.

Exclusion Criteria:

• Clinical or radiological diagnosis of pneumonia previous to the endotracheal intubation.

• Allergy to chlorhexidine.

• Known immune deficiency.

Elimination Criteria:

• Transfer to another hospital.